A Metabolomic Study Reveals Novel Plasma Lyso-Gb3 Analogs As Fabry Disease Biomarkers

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|20|2|280-288

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.20, Iss.2, 2013-01, pp. : 280-288

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel Gb3 Isoforms Detected in Urine of Fabry Disease Patients: A Metabolomic Study

By  

Current Medicinal Chemistry, Vol. 19, Iss. 19, 2012-07 ,pp. : 3241-3252

Bentham Science Publishers

Access to resources Recommend Favorite

Novel therapeutic targets for the treatment of Fabry disease

By Hollak Carla EM   Vedder Anouk C   Linthorst Gabor E   Aerts Johannes MFG  

Expert Opinion on Therapeutic Targets, Vol. 11, Iss. 6, 2007-06 ,pp. : 821-833

Informa Healthcare

Access to resources Recommend Favorite

Novel therapies show efficacy in Fabry's disease

By  

Inpharma, Vol. 1, Iss. 1296, 2001-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

The Importance of Novel Inflammatory Biomarkers in Renal Disease

By  

Current Medicinal Chemistry, Vol. 22, Iss. 23, 2015-01 ,pp. : 2786-2800

Bentham Science Publishers

Access to resources Recommend Favorite

-Galactosidase clears accumulated glycolipid GL-3 in patients with Fabry's disease

By  

Inpharma, Vol. 1, Iss. 1259, 2000-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite